Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 2
2006 2
2007 7
2008 3
2009 4
2010 7
2011 2
2012 5
2013 5
2014 4
2015 5
2016 5
2017 5
2018 5
2019 4
2020 12
2021 7
2022 4
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). Elad S, et al. Among authors: yarom n. Cancer. 2020 Oct 1;126(19):4423-4431. doi: 10.1002/cncr.33100. Epub 2020 Jul 28. Cancer. 2020. PMID: 32786044 Free PMC article.
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). Lalla RV, et al. Cancer. 2014 May 15;120(10):1453-61. doi: 10.1002/cncr.28592. Epub 2014 Feb 25. Cancer. 2014. PMID: 24615748 Free PMC article. Review.
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.
Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H, Murphy BA, Alston-Johnson D, Mendes RA, Beadle BM, Jensen SB, Saunders DP. Yarom N, et al. J Clin Oncol. 2019 Sep 1;37(25):2270-2290. doi: 10.1200/JCO.19.01186. Epub 2019 Jul 22. J Clin Oncol. 2019. PMID: 31329513
Oral Complications of Nonsurgical Cancer Therapies.
Elad S, Zadik Y, Yarom N. Elad S, et al. Among authors: yarom n. Atlas Oral Maxillofac Surg Clin North Am. 2017 Sep;25(2):133-147. doi: 10.1016/j.cxom.2017.04.006. Atlas Oral Maxillofac Surg Clin North Am. 2017. PMID: 28778303 Review. No abstract available.
Adverse Reactions to Anticancer Drugs in the Oral Cavity.
Di Fede O, Yarom N, Bagan J, Otto S, Fedele S. Di Fede O, et al. Among authors: yarom n. Biomed Res Int. 2018 Oct 2;2018:1372874. doi: 10.1155/2018/1372874. eCollection 2018. Biomed Res Int. 2018. PMID: 30370302 Free PMC article. No abstract available.
Reply to Fusco et al.
Yarom N, Peterson DE, Bohlke K, Saunders DP. Yarom N, et al. JCO Oncol Pract. 2020 Mar;16(3):145-146. doi: 10.1200/JOP.19.00716. Epub 2020 Jan 24. JCO Oncol Pract. 2020. PMID: 32048936 No abstract available.
Bisphosphonate-Related Osteonecrosis of the Jaw.
Yarom N, Goss A, Lazarovici TS, Elad S. Yarom N, et al. J Am Dent Assoc. 2016 Oct;147(10):776-7. doi: 10.1016/j.adaj.2016.08.015. J Am Dent Assoc. 2016. PMID: 27688227 No abstract available.
81 results